Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Fortress Biotech Inc. logo

Fortress Biotech Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 17 M  90-day average vol: 437,619

Previous close: 2.17  Open: 2.16  Bid: 2.58  Ask: 2.61
52 week range    
EBS / 
Last updated: Tuesday 5th December 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


FBIO Income Statement

AccruedPreferredStockDividends-299000.0-2 M-3 M-7 M-8 M-8 M
Amortization-20000.0-4 M-314000.0-692000.0-3141.0-2 M-4 M-7 M-4 M-2 M
Amortization of intangibles-509000.0-2 M-1 M-1 M
Basic EPS from continuing operations-3.95-4.95-2.59-0.79
Basic EPS total-1.21-1.48-4.01-5.21-3.72-0.79-0.97
Basic weighted shares outstanding30 M36 M39 M40 M42 M43 M55 M72 M82 M89 M
CommissionExpenses10 M
Cost of sales-141000.0-24000.0-790000.04 M6 M11 M15 M42 M-31 M
Depreciation-17000.0-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M-3 M
Depreciation unreconciled545000.0
DepreciationAndAmortization-17000.0-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M-3 M
DevelopmentExpense75 M3 M16 M700000.0
Diluted EPS total-1.22-0.56-1.24-1.38-4.01-5.21-3.72-1.43-0.79-0.97
Diluted normalized net income/share-0.65-0.79
Diluted weighted shares outstanding30 M36 M8 M130 M42 M43 M55 M72 M82 M89 M
Fees7 M104.0
GainOnSaleOfPPE18 M
GainOnSaleOfSecurity2 M18 M
GainsLossOnDisposalOfDiscontinuedOperations-2 M-13 M
GeneralAndAdministrativeExpense10 M10 M-19 M28 M51 M53 M56 M-44 M-2 M-2 M
Gross operating profit141000.03 M32 M14 M-3 M-9 M-14 M-36 M-29 M
Income before tax-37 M-20 M-54 M-71 M-98 M-131 M-102 M-103 M-164 M-213 M
Income restructuring and M&A-136000.0-154000.0-200000.0
Income taxes-67 M-2 M-10 M-12 M136000.0473000.0449000.0
Interest income545000.0266000.0-3 M-76 M819000.01 M3 M-7 M25 M-11 M
InterestExpenseNonOperating2 M-1 M-1 M-4 M-7687.0-10340.0-12 M-15 M-15 M-12 M
InterestExpenseOperating-2 M-9 M-10 M-11 M-10 M
MinorityInterests5 M16 M33 M58 M62 M56 M100 M127 M
MiscOtherSpecialCharges942000.0-438000.0-1 M-9 M11 M23 M43 M63 M75 M
Net income from total operations-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeCommonStockholders-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeContinuousOperations-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeDiscontinuousOperations-2 M-11 M
NetNonOperatingInterestIncomeExpense-1 M266000.0-3 M-76 M819000.01 M3 M-7 M25 M-11 M
Operating income-36 M-21 M-12 M-119 M-90 M-143 M-146 M-139 M-252 M-277 M
Operating income before depreciation (EBITDA)-37 M-22 M-55 M-72 M-93 M-126 M-114 M-117 M-180 M-225 M
OperatingExpense-36 M-21 M-51 M-82 M103 M141 M137 M125 M216 M249 M
Other income net-373000.0-942000.0438000.01 M9 M-11 M-42 M-43 M-63 M-75 M
Other special charges-17 M-16 M
OtherGainLossFromDispositionOfDiscontinuedOperations-810000.02 M
OtherGandA10 M10 M-19 M28 M51 M53 M56 M-44 M-2 M-2 M
OtherOperatingExpenses51 M82 M-107 M-6 M-3 M-3 M-3 M-4 M
OtherunderPreferredStockDividend-299000.0-2 M-3 M-7 M-8 M-8 M
PreferredStockDividends-299000.0-2 M-3 M-7 M-8 M-8 M
RentAndLandingFees10 M10 M-19 M28 M-1 M-2 M-2 M
Research & development expense26 M10 M-18 M41 M52 M87 M81 M64 M129 M135 M
ResearchExpense26 M10 M-18 M41 M52 M87 M6 M61 M113 M134 M
SalariesAndWages-6 M-6 M-14 M-12 M-13 M-15 M-13 M-13 M-19 M-23 M
Selling Gen & administrative expense10 M10 M-19 M28 M51 M53 M56 M61 M87 M114 M
SellingAndMarketingExpense-3 M-6 M-10 M-12 M-17 M61 M87 M114 M
SellingExpense61 M87 M114 M
Special income/charges136000.0400000.0200000.017 M17 M
Total Income available for interest expense (EBIT)-37 M-22 M-55 M-75 M-98 M-131 M-122 M-128 M-191 M-236 M
Total common shares outstanding44 M46 M49 M50 M51 M61 M78 M98 M108 M133 M
Total net income-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
Total ordinary shares9 M9 M9 M9 M9 M9 M9 M9 M9 M9 M
Total revenues3 M33 M17 M4 M2 M1 M6 M2 M
TotalExpenses-36 M-21 M-51 M-83 M107 M147 M147 M140 M257 M218 M
TotalRevenue863000.016 M17 M4 M2 M1 M6 M76 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today